ArticleInternational urology and nephrology2026
Safety evaluation of finerenone and identification of factors contributing to nephrotoxicity: re-analysis using FDA adverse event reporting system data.
Chunhui Du et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it